These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 31829928

  • 1. Clinical significance of urinary tumor necrosis factor-like weak inducer of apoptosis (TWEAK) in immunoglobulin A nephropathy
.
    Kim JS, Jeong KH.
    Clin Nephrol; 2020 Feb; 93(2):99-105. PubMed ID: 31829928
    [Abstract] [Full Text] [Related]

  • 2. TWEAK/Fn14 system and crescent formation in IgA nephropathy.
    Sasaki Y, Shimizu Y, Suzuki Y, Horikoshi S, Tomino Y.
    BMC Nephrol; 2015 Mar 14; 16():27. PubMed ID: 25885587
    [Abstract] [Full Text] [Related]

  • 3. Urinary TWEAK as a biomarker of lupus nephritis: a multicenter cohort study.
    Schwartz N, Rubinstein T, Burkly LC, Collins CE, Blanco I, Su L, Hojaili B, Mackay M, Aranow C, Stohl W, Rovin BH, Michaelson JS, Putterman C.
    Arthritis Res Ther; 2009 Mar 14; 11(5):R143. PubMed ID: 19785730
    [Abstract] [Full Text] [Related]

  • 4. Combined utilization of untimed single urine of MCP-1 and TWEAK as a potential indicator for proteinuria in lupus nephritis: A case-control study.
    Dong X, Zheng Z, Luo X, Ding J, Li Y, Li Z, Li S, Rong M, Fu Y, Wu Z, Zhu P.
    Medicine (Baltimore); 2018 Apr 14; 97(16):e0343. PubMed ID: 29668584
    [Abstract] [Full Text] [Related]

  • 5. Serum and urine TNF-like weak inducer of apoptosis, monocyte chemoattractant protein-1 and neutrophil gelatinase-associated lipocalin as biomarkers of disease activity in patients with systemic lupus erythematosus.
    Mirioglu S, Cinar S, Yazici H, Ozluk Y, Kilicaslan I, Gul A, Ocal L, Inanc M, Artim-Esen B.
    Lupus; 2020 Apr 14; 29(4):379-388. PubMed ID: 32041504
    [Abstract] [Full Text] [Related]

  • 6. Urinary Tumor Necrosis Factor-Like Weak Inducer of Apoptosis (uTWEAK) and Urinary Monocyte Chemo-attractant Protein-1 (uMCP-1): Promising Biomarkers of Lupus Nephritis Activity?
    Elsaid DS, Abdel Noor RA, Shalaby KA, Haroun RA.
    Saudi J Kidney Dis Transpl; 2021 Apr 14; 32(1):19-29. PubMed ID: 34145111
    [Abstract] [Full Text] [Related]

  • 7. Urinary MCP-1 and TWEAK as non-invasive markers of disease activity and treatment response in patients with lupus nephritis in South Africa.
    Moloi MW, Rusch JA, Omar F, Ekrikpo U, Dandara C, Bello AK, Jayne D, Okpechi IG.
    Int Urol Nephrol; 2021 Sep 14; 53(9):1865-1873. PubMed ID: 33459955
    [Abstract] [Full Text] [Related]

  • 8. Assessment of urinary TWEAK levels in Mexican patients with untreated lupus nephritis: An exploratory study.
    Reyes-Martínez F, Pérez-Navarro M, Rodríguez-Matías A, Soto-Abraham V, Gutierrez-Reyes G, Medina-Avila Z, Valdez-Ortiz R.
    Nefrologia (Engl Ed); 2018 Sep 14; 38(2):152-160. PubMed ID: 28755900
    [Abstract] [Full Text] [Related]

  • 9. Combined detection of uMCP-1 and uTWEAK for rapid discrimination of severe lupus nephritis.
    Dong XW, Zheng ZH, Ding J, Luo X, Li ZQ, Li Y, Rong MY, Fu YL, Shi JH, Yu LC, Wu ZB, Zhu P.
    Lupus; 2018 May 14; 27(6):971-981. PubMed ID: 29451067
    [Abstract] [Full Text] [Related]

  • 10. Urinary excretion of β2-microglobulin as a prognostic marker in immunoglobulin A nephropathy.
    Shin JR, Kim SM, Yoo JS, Park JY, Kim SK, Cho JH, Jeong KH, Lee TW, Ihm CG.
    Korean J Intern Med; 2014 May 14; 29(3):334-40. PubMed ID: 24851068
    [Abstract] [Full Text] [Related]

  • 11. Clinical significance of serum interleukin-8 and soluble tumor necrosis factor-like weak inducer of apoptosis levels in patients with diabetic nephropathy.
    Liu SY, Chen J, Li YF.
    J Diabetes Investig; 2018 Sep 14; 9(5):1182-1188. PubMed ID: 29489069
    [Abstract] [Full Text] [Related]

  • 12. Urinary TNF-like weak inducer of apoptosis (TWEAK) as a biomarker of lupus nephritis.
    Salem MN, Taha HA, Abd El-Fattah El-Feqi M, Eesa NN, Mohamed RA.
    Z Rheumatol; 2018 Feb 14; 77(1):71-77. PubMed ID: 27619369
    [Abstract] [Full Text] [Related]

  • 13. The Relationship between Serum TWEAK Levels and Carotid Intima-media Thickness in Patients with Fabry Disease.
    Turkmen K, Baloglu I, Aykut T, Demir S, Altın E, Akguzel ZA, Kocabas M, Yerlikaya FH.
    Saudi J Kidney Dis Transpl; 2023 Sep 01; 34(5):406-415. PubMed ID: 38995299
    [Abstract] [Full Text] [Related]

  • 14. Soluble TWEAK and atheromatosis progression in patients with chronic kidney disease.
    Fernández-Laso V, Méndez-Barbero N, Valdivielso JM, Betriu A, Fernández E, Egido J, Martín-Ventura JL, Blanco-Colio LM.
    Atherosclerosis; 2017 May 01; 260():130-137. PubMed ID: 28390291
    [Abstract] [Full Text] [Related]

  • 15. Noninvasive Urinary Monitoring of Progression in IgA Nephropathy.
    Yang JYC, Sarwal RD, Fervenza FC, Sarwal MM, Lafayette RA.
    Int J Mol Sci; 2019 Sep 10; 20(18):. PubMed ID: 31510053
    [Abstract] [Full Text] [Related]

  • 16. miR-200bc/429 cluster alleviates inflammation in IgA nephropathy by targeting TWEAK/Fn14.
    Guo Y, Liao Y.
    Int Immunopharmacol; 2017 Nov 10; 52():150-155. PubMed ID: 28910745
    [Abstract] [Full Text] [Related]

  • 17. NLRC5: potential novel non-invasive biomarker for predicting and reflecting the progression of IgA nephritis.
    Chen Y, Li H, Xiao C, Zeng X, Xiao X, Zhou Q, Xiao P.
    J Transl Med; 2018 Nov 19; 16(1):317. PubMed ID: 30453994
    [Abstract] [Full Text] [Related]

  • 18. High levels of urinary complement proteins are associated with chronic renal damage and proximal tubule dysfunction in immunoglobulin A nephropathy.
    Wen L, Zhao Z, Wang Z, Xiao J, Birn H, Gregersen JW.
    Nephrology (Carlton); 2019 Jul 19; 24(7):703-710. PubMed ID: 30141239
    [Abstract] [Full Text] [Related]

  • 19. High serum and urine neutrophil gelatinase-associated lipocalin levels are independent predictors of renal progression in patients with immunoglobulin A nephropathy.
    Rhee H, Shin N, Shin MJ, Yang BY, Kim IY, Song SH, Lee DW, Lee SB, Kwak IS, Seong EY.
    Korean J Intern Med; 2015 May 19; 30(3):354-61. PubMed ID: 25995666
    [Abstract] [Full Text] [Related]

  • 20. Soluble Tumor Necrosis Factor (TNF)-Like Weak Inducer of Apoptosis (Tweak) Independently Predicts Subclinical Atherosclerosis in Behcet's Disease.
    Icli A, Cure MC, Cure E, Arslan S, Unal M, Sakiz D, Ozucan M, Toker A, Turkmen K, Kucuk A.
    Acta Medica (Hradec Kralove); 2018 May 19; 61(3):86-92. PubMed ID: 30543512
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.